Table 1.

Baseline demographics and risk factors by treatment arm among patients with a 12-month follow-up visit in the Steroids for Corneal Ulcers Trial (N=399^a)

Characteristic	Placebo		Steroid		Total		P-value
	N or median	% or IQRb	N or median	% or IQRb	N or median	% or IQRb
Gender
Male	118	59.9	98	48.5	216	54.1	0.03
Enrollment Site
India	192	97.5	197	97.5	389	97.5	1.00
United States	5	2.5	5	2.5	10	2.5
Age (years)	50	(40–60)	52	(40–61)	51	(40–60)	0.67
Occupation
Manual Labor – Agriculture	93	47.2	87	43.1	180	45.1	0.36
Manual Labor – Non-agriculture	40	20.3	38	18.8	78	19.5
Professional/Business/Service	18	9.1	13	6.4	31	7.8
Domestic work	10	5.1	16	7.9	26	6.5
Semi-skilled/Skilled labor	9	4.6	7	3.5	16	4.0
Not workingc	27	13.7	41	20.3	68	17.0
Medication use at enrollmentd
Topical antibiotics	63	32.0	73	36.1	136	34.1	0.40
Other topical ocular dropse	42	21.3	49	24.3	91	22.8	0.55
Unspecified topical drops	44	22.3	42	20.8	86	21.6	0.72
Native medicinesf	2	1.0	4	2.0	6	1.5	0.69
Systemic antibiotics	3	1.5	4	2.0	7	1.8	1.00
Systemic aspirin/NSAIDsg	5	2.5	5	2.5	10	2.5	1.00
Other systemic	6	3.0	9	4.5	15	3.8	0.60
Objects that caused trauma or injury
Vegetative matter/Wood	67	34.0	80	39.6	147	36.8	0.26
Metal/Otherh	52	26.4	44	21.8	96	24.1	0.29
Unknown object	16	8.1	10	5.0	26	6.5	0.23
Contact lens	3	1.5	4	2.0	7	1.8	1.00
Total	197	100.0	202	100.0	399	100.0	-

^aIncludes only those participants with a 12-month follow-up visit within the pre-specified window of 10–14 months from enrollment

^bInter-quartile range

^cIncludes unemployed, retired, etc.

^dSome patients were taking more than 1 medication at enrollment

^eIncludes topical antifungals, dilating drops, glaucoma medication, and lubricating drops

^fIncludes castor oil, goat’s milk, breast milk, and coconut oil

^gNon-steroidal anti-inflammatory drugs

^hIncludes dust, finger, sand, cow’s tail, and insect